Mealey's (May 20, 2019, 8:48 AM EDT) -- HUNTINGDON, W.Va. — A West Virginia federal judge on May 15 denied judgment as a matter of law (JMOL) or a new trial to drug maker Boehringer Ingelheim Pharmaceuticals Inc. in a Pradaxa anticoagulant case, preserving a $1.7 million verdict that included punitive damages (Claude R. Knight, et al. ex rel. Betty Erelene Knight v. Boehringer Ingelheim Pharmaceuticals, Inc., No. 15-6424, S.D. W.Va., Huntington Div., 2019 U.S. Dist. LEXIS 81728)....